Nixen exits Ceva Santé Animale
Nixen has sold its stake in French veterinary laboratory Ceva Santé Animale as part of the company’s management buyout, which sees Sagard and Euromezzanine reinvest alongside new backers.
More on France
Goldman Sachs, Kennet sell Nuxeo to Hyland Software
Goldman Sachs and Kennet Partners are expected to make a 5x return on their investment in Nuxeo
Sofinnova Crossover Fund closes on €445m
Fund focuses on investments in later-stage biopharma and medtech companies that need capital to scale up
Biotech market provides dose of optimism
In the past year, the biotech market has seen buoyant activity, reaching record levels of investments
Tikehau to become majority shareholder in Cruiseline
Following the deal, Montefiore retains a minority stake and a seat on the company's board
Latest News
LDC buys Sohonet from FPE Capital
With LDC's support, the company intends to boost its international growth and explore complementary acquisitions
Goldman Sachs, Kennet sell Nuxeo to Hyland Software
Goldman Sachs and Kennet Partners are expected to make a 5x return on their investment in Nuxeo
BGF-backed TIG bolts on ThirdSpace
Acquisition of the cybersecurity and identity firm is backed by BGF and Santander Growth Capital
BGF invests in Leeds company Northern Building Plastics
GP's backing will help the company expand its service, delivery capability, and product range